Buscar resultados de ensayos clínicos
Microsatellite Instability - 23 Studies Found
Estado | Estudiar |
Not yet recruiting |
Nombre del estudio: Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Microsatellite Instability-High Metastatic Colorectal Cancer Condición:
|
Not yet recruiting |
Nombre del estudio: Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair or Microsatellite Instability Condición:
|
Recruiting |
Nombre del estudio: Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177) Condición: Colorectal Carcinoma Fecha: 2015-09-28 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: Durvalumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Condición:
|
Recruiting |
Nombre del estudio: A Phase II Study of Tegafur-Uracil as Maintenance Chemotherapy in Patients With Stage II of Colon Cancer Condición:
Fecha: 2016-08-01 Intervenciones: Drug: tegafur-uracil |
Completed |
Nombre del estudio: Efficacy and Safety of Olaparib in Pretreated Patients With Measurable Colorectal Cancer, Stratified by Microsatellite Instability (MSI) Status Condición: Colorectal Cancer Fecha: 2009-05-28 Intervenciones: Drug: olaparib 400 mg po bid continuously |
Completed |
Nombre del estudio: Genetic Study of Young Patients With Colorectal Cancer Condición: Colorectal Cancer Fecha: 2002-09-06 Intervenciones: Genetic: microsatellite instability analysis |
Recruiting |
Nombre del estudio: Tissue Microarrays (TMAs) Construction in Lung Cancer Samples Condición: Lung Cancer Fecha: 2017-04-21 |
Recruiting |
Nombre del estudio: Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Metastatic Colorectal Adenocarcinoma Condición: Metastatic Colorectal Adenocarcinoma Fecha: 2012-07-09 Intervenciones:
|
Recruiting |
Nombre del estudio: A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors Condición:
|